Total planned funding: $236,338,570
Allocations
Countries/Regions
Eswatini | $236,338,570 |
Organizational Types
Private Contractor | $63,168,011 |
NGO | $48,989,692 |
University | $42,080,355 |
Unknown | $32,293,601 |
Own Agency | $25,763,265 |
FBO | $8,611,975 |
Host Country Government Agency | $7,875,888 |
Multi-lateral Agency | $7,002,970 |
Other USG Agency | $552,813 |
Program Areas
Care | $80,716,571 |
Treatment | $50,045,566 |
Prevention | $45,086,145 |
Testing | $23,397,301 |
Governance and Systems | $22,501,494 |
Management and Operations | $14,591,493 |
Budget Codes
HBHC: Care: Adult Care and Support | $40,118,677 |
HTXS: Treatment: Adult Treatment | $37,922,778 |
HVCT: Testing: HIV Testing and Counseling | $23,397,301 |
HKID: Care: Orphans and Vulnerable Children | $22,972,061 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $17,440,623 |
HVMS: Management and Operations | $14,591,493 |
HVOP: Sexual Prevention: Other Sexual Prevention | $13,005,626 |
HVTB: Care: TB/HIV | $11,148,187 |
HVSI: Strategic Information | $9,599,619 |
OHSS: Health Systems Strengthening | $9,491,683 |
HTXD: Treatment: ARV Drugs | $9,403,830 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,861,031 |
PDCS: Care: Pediatric Care and Support | $6,477,646 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $6,111,894 |
HLAB: Laboratory Infrastructure | $3,410,192 |
PDTX: Treatment: Pediatric Treatment | $2,718,958 |
HMBL: Biomedical Prevention: Blood Safety | $666,971 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$35,287,820
Countries/Regions
Not Available:
$27,894,615
Countries/Regions
Pact, Inc.:
$26,692,112
Countries/Regions
USG Aggregated Agencies:
$18,464,513
Countries/Regions